CYP46A1 and Alzheimer disease: Injections of adeno-associated virus encoding CYP46A1 in the hippocampus of AD mouse models reduced amyloid β (Aβ) burden and restored spatial memory performance (16, 17), while Cyp46a1 inhibition led to opposite effects (18).